| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy
|
Fulbright, Joy Marie
|
|
2015
|
76 |
6 |
p. 1297-1307
|
artikel
|
| 2 |
Antimitotic drugs in the treatment of cancer
|
Vuuren, Rustelle Janse van
|
|
2015
|
76 |
6 |
p. 1101-1112
|
artikel
|
| 3 |
A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors
|
Nakamichi, Shinji
|
|
2015
|
76 |
6 |
p. 1153-1161
|
artikel
|
| 4 |
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients
|
Francis, Jose
|
|
2015
|
76 |
6 |
p. 1185-1189
|
artikel
|
| 5 |
Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer
|
Kurihara, Tatsuya
|
|
2015
|
76 |
6 |
p. 1217-1224
|
artikel
|
| 6 |
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO)
|
Hata, Taishi
|
|
2015
|
76 |
6 |
p. 1209-1215
|
artikel
|
| 7 |
Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients
|
Liu, Ping
|
|
2015
|
76 |
6 |
p. 1163-1171
|
artikel
|
| 8 |
Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug–drug interaction
|
Koršić, Marta
|
|
2015
|
76 |
6 |
p. 1317-1319
|
artikel
|
| 9 |
Evaluation of the safety and pathological effects of neoadjuvant full-dose gemcitabine combination radiation therapy in patients with biliary tract cancer
|
Kobayashi, Shogo
|
|
2015
|
76 |
6 |
p. 1191-1198
|
artikel
|
| 10 |
Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression
|
Peng, Xianbing
|
|
2015
|
76 |
6 |
p. 1173-1184
|
artikel
|
| 11 |
Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells
|
Wang, Lijun
|
|
2015
|
76 |
6 |
p. 1247-1257
|
artikel
|
| 12 |
Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation
|
Lee, Oukseub
|
|
2015
|
76 |
6 |
p. 1235-1246
|
artikel
|
| 13 |
Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study
|
Kim, Young Saing
|
|
2015
|
76 |
6 |
p. 1267-1272
|
artikel
|
| 14 |
Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts
|
Lee, Nikki P.
|
|
2015
|
76 |
6 |
p. 1199-1207
|
artikel
|
| 15 |
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
|
Fox, Elizabeth
|
|
2015
|
76 |
6 |
p. 1273-1283
|
artikel
|
| 16 |
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
|
Deenen, Maarten J.
|
|
2015
|
76 |
6 |
p. 1285-1295
|
artikel
|
| 17 |
Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
|
Wu, Zheng
|
|
2015
|
76 |
6 |
p. 1309-1314
|
artikel
|
| 18 |
Phase I study of nintedanib in combination with pemetrexed as second-line treatment of Japanese patients with advanced non-small cell lung cancer
|
Daga, Haruko
|
|
2015
|
76 |
6 |
p. 1225-1233
|
artikel
|
| 19 |
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors
|
Fujiwara, Yutaka
|
|
2015
|
76 |
6 |
p. 1143-1152
|
artikel
|
| 20 |
Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma
|
Galsky, Matthew D.
|
|
2015
|
76 |
6 |
p. 1259-1265
|
artikel
|
| 21 |
Schedule-dependent modulation of the pharmacokinetics of MK-2206, an oral pan-AKT inhibitor: perspectives
|
Srinivas, Nuggehally R.
|
|
2015
|
76 |
6 |
p. 1315-1316
|
artikel
|
| 22 |
Targeted therapy in cancer
|
Tsimberidou, Apostolia-Maria
|
|
2015
|
76 |
6 |
p. 1113-1132
|
artikel
|
| 23 |
The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
|
Jin, F.
|
|
2015
|
76 |
6 |
p. 1133-1141
|
artikel
|
Tijdschrift beschrijving